212 related articles for article (PubMed ID: 1677669)
1. A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and natural killer cells.
Samstag Y; Bader A; Meuer SC
J Immunol; 1991 Aug; 147(3):788-94. PubMed ID: 1677669
[TBL] [Abstract][Full Text] [Related]
2. Stimulation via CD3-Ti but not CD2 induces rapid tyrosine phosphorylation of a 68-kDa protein in the human Jurkat T cell line.
Jin YJ; Kaplan DR; White M; Spagnoli GC; Roberts TM; Reinherz EL
J Immunol; 1990 Jan; 144(2):647-52. PubMed ID: 1688582
[TBL] [Abstract][Full Text] [Related]
3. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
[TBL] [Abstract][Full Text] [Related]
4. Activation of human T lymphocytes via the CD2 antigen results in tyrosine phosphorylation of T cell antigen receptor zeta-chains.
Monostori E; Desai D; Brown MH; Cantrell DA; Crumpton MJ
J Immunol; 1990 Feb; 144(3):1010-4. PubMed ID: 1688586
[TBL] [Abstract][Full Text] [Related]
5. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase.
Samelson LE; Fletcher MC; Ledbetter JA; June CH
J Immunol; 1990 Oct; 145(8):2448-54. PubMed ID: 1976695
[TBL] [Abstract][Full Text] [Related]
6. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
[TBL] [Abstract][Full Text] [Related]
7. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes.
Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F
J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400
[TBL] [Abstract][Full Text] [Related]
8. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes.
Hivroz-Burgaud C; Clipstone NA; Cantrell DA
Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154
[TBL] [Abstract][Full Text] [Related]
9. CD2 can mediate TCR/CD3-independent T cell activation.
Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
[TBL] [Abstract][Full Text] [Related]
10. Cholera toxin modulates the T cell antigen receptor/CD3 complex but not the CD2 molecule and inhibits signaling via both receptor structures in the human T cell lymphoma Jurkat.
Sommermeyer H; Schwinzer R; Kaever V; Wessel K; Schmidt RE; Behl B; Wonigeit K; Szamel M; Resch K
Eur J Immunol; 1989 Dec; 19(12):2387-90. PubMed ID: 2575034
[TBL] [Abstract][Full Text] [Related]
11. The T cell receptor/CD3 complex and CD2 stimulate the tyrosine phosphorylation of indistinguishable patterns of polypeptides in the human T leukemic cell line Jurkat.
Ley SC; Davies AA; Druker B; Crumpton MJ
Eur J Immunol; 1991 Sep; 21(9):2203-9. PubMed ID: 1679714
[TBL] [Abstract][Full Text] [Related]
12. The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells.
Breitmeyer JB; Daley JF; Levine HB; Schlossman SF
J Immunol; 1987 Nov; 139(9):2899-905. PubMed ID: 2444644
[TBL] [Abstract][Full Text] [Related]
13. CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytes.
Graves JD; Downward J; Rayter S; Warne P; Tutt AL; Glennie M; Cantrell DA
J Immunol; 1991 Jun; 146(11):3709-12. PubMed ID: 1674518
[TBL] [Abstract][Full Text] [Related]
14. Evidence that protein kinase C differentially regulates the human T lymphocyte CD2 and CD3 surface antigens.
Cantrell DA; Verbi W; Davies A; Parker P; Crumpton MJ
Eur J Immunol; 1988 Sep; 18(9):1391-6. PubMed ID: 2901966
[TBL] [Abstract][Full Text] [Related]
15. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
[TBL] [Abstract][Full Text] [Related]
16. Serine 16 of stathmin as a cytosolic target for Ca2+/calmodulin-dependent kinase II after CD2 triggering of human T lymphocytes.
le Gouvello S; Manceau V; Sobel A
J Immunol; 1998 Aug; 161(3):1113-22. PubMed ID: 9686569
[TBL] [Abstract][Full Text] [Related]
17. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
[TBL] [Abstract][Full Text] [Related]
19. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.
Danielian S; Fagard R; Alcover A; Acuto O; Fischer S
Eur J Immunol; 1989 Dec; 19(12):2183-9. PubMed ID: 2481585
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
